MedPath

北京托毕西药业有限公司

Ownership
-
Established
1993-11-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Dexamethasone Palmitate

Product Name
地塞米松棕榈酸酯
Approval Number
国药准字H20100169
Approval Date
Apr 16, 2025
NMPA

Batroxobin Injection

Product Name
东菱迪芙
Approval Number
国药准字H20031074
Approval Date
Jun 30, 2021
NMPA

Batroxobin Injection

Product Name
东菱迪芙
Approval Number
国药准字H20030295
Approval Date
Sep 4, 2020
NMPA

Dexamethasone Palmitate Injection

Product Name
地塞米松棕榈酸酯注射液
Approval Number
国药准字H20103579
Approval Date
Apr 17, 2020
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H20046253
Approval Date
Nov 26, 2004
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H20046252
Approval Date
Nov 26, 2004
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液
Approval Number
国药准字H20044148
Approval Date
Jun 24, 2004
NMPA

Heparin Sodium Injection

Product Name
肝素钠注射液
Approval Number
国药准字H20043741
Approval Date
Apr 30, 2004
NMPA

Heparin Sodium Injection

Product Name
肝素钠注射液
Approval Number
国药准字H20043740
Approval Date
Apr 30, 2004
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.